THE PTEN TUMOR-SUPPRESSOR GENE AND MALIGNANT-MELANOMA

Citation
R. Boni et al., THE PTEN TUMOR-SUPPRESSOR GENE AND MALIGNANT-MELANOMA, Melanoma research, 8(4), 1998, pp. 300-302
Citations number
16
Categorie Soggetti
Oncology,"Dermatology & Venereal Diseases","Medicine, Research & Experimental
Journal title
ISSN journal
09608931
Volume
8
Issue
4
Year of publication
1998
Pages
300 - 302
Database
ISI
SICI code
0960-8931(1998)8:4<300:TPTGAM>2.0.ZU;2-D
Abstract
A candidate tumour suppressor gene, PTEN, has recently been identified within chromosome 10q23, the locus of the Cowden syndrome/Lhermitte-D uclos disease susceptibility gene. Cowden disease is an autosomal domi nant cancer predisposition syndrome associated with tumours of the bre ast, thyroid and, less frequently, malignant melanoma. Based on the id entification of mutations in sporadic breast, brain and prostate tumou rs, we decided to examine the potential role of PTEN in sporadic malig nant melanoma. Frozen tissue from primary cutaneous melanomas (n = 23) and metastases (n = 17) were microdissected, and microsatellite marke rs D10S541 and D10S547, flanking the gene on both sides, were used to search for loss of heterozygosity (LOH) in the PTEN gene locus. To ide ntify mutations within the putative tumour suppressor gene, we perform ed single strand conformation polymorphism (SSCP) analysis using intro nic primers to amplify exons 5, 6, 7 and 8 of the PTEN gene. No LOH wa s detected using the polymorphic markers D10S541 and D105547. SSCP ana lysis revealed no aberrant bands in the tumour specimen. Our results s uggest that the PTEN gene does not play a major role in the initiation and progression of melanoma. (C) 1998 Lippincott Williams & Wilkins.